The Center of Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University is involved in various different aspects of developing, evaluating and applying novel quantitative image analysis, computer vision, signal processing, segmentation, multi-modal co-registration tools, pattern recognition, and machine learning tools for disease diagnosis, prognosis, and theragnosis in the context of breast, prostate, head and neck, and brain tumors as well as epilepsy and carotid plaque. Our group is also exploring the utility of these methods in studying correlations of disease markers across multiple scales, modalities, and functionalities -- from gene and protein expression to spectroscopy to digital pathology and to multi-parametric MRI.


Facebook Live Stream with Anant

Latest News:

Thu, 2021-02-25 00:13

On February 16th, a patent was awarded to inventors from the Center for Computational Imaging and Personalized Diagnostics (CCIPD): “Probabilistic atlases of post-treatment multi-parametric MRI scans reveal distinct hemispheric distribution of glioblastoma progression versus pseudo-progression”. Congratulations to Pallavi Tiwari, PhD, assistant professor, biomedical engineering, CCIPD lead faculty, and leader of the BRIC Lab; Marwa Ismail, research associate with CCIPD and BRIC Lab; and Anant Madabhushi, PhD, Donnell Institute Professor, biomedical engineering, and director of...

Thu, 2021-02-25 00:09

Members of the Center for Computational Imaging and Personalized Diagnostics presented at the Technical Workshop: Computer-Aided Diagnosis on February 17th of the Society of Photo-optical Instrumentation Engineers (SPIE) Medical Imaging conference. 

RadxTools took first place at the SPIE Medical Imaging for the second year in a row. Kudos to CCIPD graduate student researchers Hyemin Um and Tom DeSilvio. Um is mentored by Dr. Pallavi Tiwari, and DeSilvio is mentored by Dr. Satish Viswanath.

The CCIPD tools showcased at the event are being actively developed. Learn more...

Thu, 2021-02-25 00:03

Anant Madabhushi, PhD, gave a presentation at the Immuno-Oncology 360° conference.
His talk titled, “Applying a Novel AI Approach to Concluded Clinical Trial Data to Predict Response to Cancer Immunotherapy ”, was part of the “Advancements in IO Imaging“  track held on February 24th. 

The conference is held virtually and spans four days.
Learn more about the conference on the Immuno-Oncology 360° website.

Wed, 2021-02-24 22:59

The Global Engage article, “Machine Learning Advances Diagnostics And Prognostics,” highlights Dr. Anant Madabhushi’s talk at the 7th Digital Pathology and AI Congress on the implications of AI in improving cancer diagnosis and better assessing the value of different cancer therapies. Global Engage is the organizer of the 7th Digital Pathology and AI Congress and an international producer of conferences in the medical sector.

Read the full article on the ...

Mon, 2021-02-15 20:09

Anant Madabhushi, PhD, will be speaking at the Tata Memorial Centre’s XIX Annual Conference, Evidence Based Management of Cancers In India: Technology and Cancer Care - Promise and Reality of the Brave New World.. His talk titled, “Pathomics for Precision Oncology”, will be held on March 7th, 2021, 8:00am - 8:30am EST. 

Tata Memorial Centre has championed Evidence Based Management in oncology in India and has hosted an annual meeting on the topic for 18 years.

Learn more and register to listen to the talk here on the EBM 2021...